T

TriSalus Life Sciences Inc
NASDAQ:TLSI

Watchlist Manager
TriSalus Life Sciences Inc
NASDAQ:TLSI
Watchlist
Price: 3.26 USD -5.51% Market Closed
Market Cap: $200.2m

Wall St Price Targets

TLSI Price Targets Summary
TriSalus Life Sciences Inc

Wall Street analysts forecast TLSI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLSI is 9.38 USD with a low forecast of 7.07 USD and a high forecast of 11.55 USD.

Lowest Forecast
Price Target
7.07 USD
117% Upside
Average Forecast
Price Target
9.38 USD
188% Upside
Highest Forecast
Price Target
11.55 USD
254% Upside
TriSalus Life Sciences Inc Competitors:
Price Targets
ELIX
Elixirr International PLC
56% Upside

Revenue
Forecast

N/A
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Revenue over the next 8 years is 26%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-56%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-56%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TLSI's stock price target?
Price Target
9.38 USD

According to Wall Street analysts, the average 1-year price target for TLSI is 9.38 USD with a low forecast of 7.07 USD and a high forecast of 11.55 USD.

What is the Revenue forecast for TriSalus Life Sciences Inc?
Projected CAGR
26%

The compound annual growth rate for Revenue over the next 8 years is 26%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett